Tanakaya Kohji, Yamaguchi Tatsuro, Ishikawa Hideki, Hinoi Takao, Furukawa Yoichi, Hirata Keiji, Saida Yoshihisa, Shimokawa Mototsugu, Arai Masami, Matsubara Nagahide, Tomita Naohiro, Tamura Kazuo, Sugano Kokichi, Ishioka Chikashi, Yoshida Teruhiko, Ishida Hideyuki, Watanabe Toshiaki, Sugihara Kenichi
Department of Surgery, Iwakuni Clinical Center, Iwakuni, Japan.
Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Anticancer Res. 2016 Apr;36(4):1985-9.
To elucidate the causes of cancer death in Japanese families with Lynch syndrome (LS).
The distributions of cancer deaths in 485 individuals from 67 families with LS (35, 30, and two families with MutL homologue 1 (MLH1), MSH2, and MSH6 gene mutations, respectively), obtained from the Registry of the Japanese Society for Cancer of the Colon and Rectum were analyzed.
Among 98 cancer deaths of first-degree relatives of unknown mutation status, 53%, 19%, 13% (among females), 7% (among females) and 5% were due to colorectal, gastric, uterine, ovarian, and hepatobiliary cancer, respectively. The proportion of deaths from extra-colonic cancer was significantly higher in families with MSH2 mutation than in those with MLH1 mutation (p=0.003).
In addition to colonic and uterine cancer, management and surveillance targeting gastric, ovarian and hepatobiliary cancer are considered important for Japanese families with LS. Extra-colonic cancer in families with MSH2 mutation might require for more intensive surveillance.
阐明林奇综合征(LS)日本家庭中癌症死亡的原因。
分析了从日本结直肠癌学会登记处获得的67个LS家庭中485名个体的癌症死亡分布情况(分别有35、30和2个家庭存在错配修复蛋白MutL同源物1(MLH1)、错配修复蛋白2(MSH2)和错配修复蛋白6(MSH6)基因突变)。
在98例突变状态不明的一级亲属癌症死亡病例中,分别有53%、19%、13%(女性中)、7%(女性中)和5%死于结直肠癌、胃癌、子宫癌、卵巢癌和肝胆癌。MSH2基因突变家庭中结肠外癌症死亡比例显著高于MLH1基因突变家庭(p = 0.000)。
对于日本LS家庭,除结肠癌和子宫癌外,针对胃癌、卵巢癌和肝胆癌的管理和监测也很重要。MSH2基因突变家庭中的结肠外癌症可能需要更密切的监测。